HRP20170270T1 - Metoda davanja plućnog surfaktanta - Google Patents

Metoda davanja plućnog surfaktanta Download PDF

Info

Publication number
HRP20170270T1
HRP20170270T1 HRP20170270TT HRP20170270T HRP20170270T1 HR P20170270 T1 HRP20170270 T1 HR P20170270T1 HR P20170270T T HRP20170270T T HR P20170270TT HR P20170270 T HRP20170270 T HR P20170270T HR P20170270 T1 HRP20170270 T1 HR P20170270T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical kit
pharmaceutical
kit
respiratory distress
distress syndrome
Prior art date
Application number
HRP20170270TT
Other languages
English (en)
Inventor
Egbert Herting
Wolfgang Gopel
Paolo Chiesi
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of HRP20170270T1 publication Critical patent/HRP20170270T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42Respiratory system, e.g. lungs, bronchi or lung cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0082Lung surfactant, artificial mucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (12)

1. Farmaceutski komplet (engl. kit) za upotrebu u sprječavanju i/ili liječenju respiratornog distresnog sindroma koji sadrži: a) farmaceutski pripravak koji sadrži od 40 do 80 mg/ml plućnog surfaktanta suspendiranog u ne više od 3.0 ml farmaceutski prihvatljivog vodenog medija u jedinici doze, a rečeni pripravak ima viskoznost manju od 20 mPas; b) tanku cijev koja ima promjer od 5 Fr; c) injekciju za davanje surfaktanta kontroliranom brzinom koja ima mrtvi volumen manji od 0.5 ml; te d) spremnik koji sadržava oblik doze, tanku cijev i injekciju.
2. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 1, naznačeno time da je tanka cijev odabrana iz skupine koja se sastoji od gastrične sonde, nazogastrične sonde, te arterijskog ili usisnog katetera.
3. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 1 ili 2, naznačeno time da je farmaceutski prihvatljiv vodeni medij puferirana fiziološka vodena otopina kuhinjske soli.
4. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 3, naznačeno time da je farmaceutski pripravak sterilan.
5. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 4, naznačeno time da je jedinica doze u jednokratnoj staklenoj bočici.
6. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 5, naznačeno time da je sterilan farmaceutski pripravak izravno dodan u napravu korištenu za davanje surfaktanta pri kontroliranoj brzini.
7. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 1, naznačeno time da volumen farmaceutski prihvatljivog vodenog medija nije veći od 2 ml.
8. Farmaceutski komplet za upotrebu kako je prijavljen u bilo kojem od prethodnih patentnih zahtjeva, naznačeno time da farmaceutski pripravak ima viskoznost između 5 i 15 mPas.
9. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 8, naznačeno time da viskoznost jest između 6 i 10 mPas.
10. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 9, naznačeno time da plućni surfaktant jest poraktant alfa.
11. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 1, naznačeno time da respiratorni distresni sindrom jest dječji respiratorni distresni sindrom (IRDS).
12. Farmaceutski komplet za upotrebu kako je prijavljen u patentnom zahtjevu 1, naznačeno time da je respiratorni distresni sindrom uzrokovan aspiracijom mekonija ili plućnom infekcijom.
HRP20170270TT 2007-06-08 2017-02-21 Metoda davanja plućnog surfaktanta HRP20170270T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/811,351 US8048043B2 (en) 2007-06-08 2007-06-08 Method of administration of a pulmonary surfactant
EP14150705.3A EP2719391B1 (en) 2007-06-08 2008-05-23 A method of administration of a pulmonary surfactant

Publications (1)

Publication Number Publication Date
HRP20170270T1 true HRP20170270T1 (hr) 2017-04-21

Family

ID=39832595

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20150966TT HRP20150966T1 (hr) 2007-06-08 2015-09-14 Metoda davanja pluä†nog surfaktanta
HRP20170270TT HRP20170270T1 (hr) 2007-06-08 2017-02-21 Metoda davanja plućnog surfaktanta

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HRP20150966TT HRP20150966T1 (hr) 2007-06-08 2015-09-14 Metoda davanja pluä†nog surfaktanta

Country Status (23)

Country Link
US (2) US8048043B2 (hr)
EP (2) EP2164504B1 (hr)
JP (1) JP5490683B2 (hr)
KR (2) KR101344159B1 (hr)
CN (1) CN101765431B (hr)
AU (1) AU2008258872B2 (hr)
BR (1) BRPI0811387B8 (hr)
CA (1) CA2690097C (hr)
CY (2) CY1116680T1 (hr)
DK (2) DK2164504T3 (hr)
EA (1) EA016308B1 (hr)
ES (2) ES2547489T3 (hr)
HK (1) HK1141457A1 (hr)
HR (2) HRP20150966T1 (hr)
HU (2) HUE025957T2 (hr)
LT (1) LT2719391T (hr)
ME (1) ME02327B (hr)
MX (2) MX359316B (hr)
PL (2) PL2164504T3 (hr)
PT (2) PT2719391T (hr)
RS (2) RS54196B1 (hr)
SI (2) SI2164504T1 (hr)
WO (1) WO2008148469A1 (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475373B1 (en) * 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
RU2504395C1 (ru) * 2012-07-13 2014-01-20 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ/ФГБУ "РНЦРХТ" Минздравсоцразвития России Способ профилактики бронхолегочной дисплазии у новорожденных с очень низкой и экстремально низкой массой тела при рождении
ITMI20150033U1 (it) * 2015-02-13 2016-08-13 Chiesi Farm Spa Catetere per la somministrazione di un surfattante polmonare
EP3277351B1 (en) 2015-04-02 2019-06-05 Hill-Rom Services PTE. LTD. Manifold for respiratory device
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
WO2016174269A1 (en) * 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
MA46605A (fr) 2016-10-26 2021-06-02 Chiesi Farm Spa Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
JP2020502242A (ja) 2016-12-22 2020-01-23 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 進行性のbpdの処置のための肺サーファクタント及びステロイドを含む処置的組み合わせ物
AU2019260526A1 (en) 2018-04-23 2020-11-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
MA54367A (fr) 2018-12-06 2021-11-10 Chiesi Farm Spa Dispositif de contrôle des voies aériennes à masque laryngé et procédé d'administration d'un médicament à travers un dispositif de contrôle des voies aériennes à masque laryngé
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
AU2022306466A1 (en) * 2021-07-05 2024-02-15 Chiesi Farmaceutici S.P.A. Process for the preparation of a pulmonary surfactant
CN115634199B (zh) * 2022-10-18 2024-05-03 杭州汉库医药科技有限公司 一种混悬型肺表面活性物质注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
GB9524007D0 (en) * 1995-11-23 1996-01-24 Bangham Alec D Endotrachael tubes with pulmonary medicaments
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
WO2003035679A2 (en) * 2001-10-25 2003-05-01 Medical Research Council Molecules
EP1897577B1 (de) * 2002-08-02 2012-05-16 Med In Medical Innovations GmbH Vorrichtung zur Erzeugung eines kontinuierlichen positiven Atemwegdrucks (CPAP-Vorrichtung)
US20060040860A1 (en) * 2004-06-17 2006-02-23 Mario Ruediger Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia
US20060112961A1 (en) * 2004-11-29 2006-06-01 Hany Aly Pediatric mask, especially suited for premature infants
ES2380046T3 (es) * 2005-01-06 2012-05-08 Discovery Laboratories, Inc. Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar

Also Published As

Publication number Publication date
EP2719391B1 (en) 2016-11-30
US20120017896A1 (en) 2012-01-26
KR101399738B1 (ko) 2014-05-27
AU2008258872B2 (en) 2012-10-04
KR101344159B1 (ko) 2013-12-23
HK1141457A1 (en) 2010-11-12
CN101765431B (zh) 2013-04-03
KR20100028530A (ko) 2010-03-12
RS55733B1 (sr) 2017-07-31
US8905979B2 (en) 2014-12-09
US20080305180A1 (en) 2008-12-11
PL2719391T3 (pl) 2017-06-30
EP2164504A1 (en) 2010-03-24
MX359316B (es) 2018-09-25
RS54196B1 (en) 2015-12-31
CA2690097C (en) 2018-05-22
JP2010528729A (ja) 2010-08-26
BRPI0811387B8 (pt) 2021-05-25
EA016308B1 (ru) 2012-04-30
KR20130038940A (ko) 2013-04-18
ES2616727T3 (es) 2017-06-14
SI2164504T1 (sl) 2015-10-30
ME02327B (me) 2016-06-20
PT2164504E (pt) 2015-10-16
DK2164504T3 (en) 2015-10-12
HRP20150966T1 (hr) 2015-10-09
WO2008148469A1 (en) 2008-12-11
BRPI0811387A2 (pt) 2015-07-21
EA200901499A1 (ru) 2010-06-30
CA2690097A1 (en) 2008-12-11
HUE031750T2 (en) 2017-07-28
BRPI0811387B1 (pt) 2018-11-06
PT2719391T (pt) 2017-03-02
AU2008258872A1 (en) 2008-12-11
PL2164504T3 (pl) 2016-01-29
DK2719391T3 (en) 2017-02-20
SI2719391T1 (sl) 2017-03-31
JP5490683B2 (ja) 2014-05-14
MX2009012835A (es) 2009-12-15
US8048043B2 (en) 2011-11-01
ES2547489T3 (es) 2015-10-06
CN101765431A (zh) 2010-06-30
HUE025957T2 (en) 2016-05-30
EP2164504B1 (en) 2015-07-29
CY1116680T1 (el) 2017-03-15
CY1118635T1 (el) 2017-07-12
EP2719391A1 (en) 2014-04-16
LT2719391T (lt) 2017-02-10

Similar Documents

Publication Publication Date Title
HRP20170270T1 (hr) Metoda davanja plućnog surfaktanta
HRP20191994T1 (hr) Formulacije ketorolaka spremne za uporabu
NO126298B (hr)
CN101836952B (zh) 一种氨溴索注射剂及其制备方法
HRP20211520T1 (hr) Postupci i pripravci za dostavu iduronat-2-sulfataze u središnji živčani sustav
JP2016501066A5 (hr)
JP2016539921A5 (hr)
HRP20121036T1 (hr) Intranazalni spojevi
HRP20150393T1 (hr) Komplet za parenteralno davanje lijekova
HRP20130150T1 (hr) Sustav pakiranja farmaceutskih sastava i komplet za intravenozno davanje
CN105311081A (zh) 山海丹野菊花注射液在雾化吸入、喷瓶气雾、直肠给药的应用及方法
RU2017129375A (ru) Интестинальный гель на основе леводопы и карбидопы и способы его применения
WO2007022609B1 (en) Pharmaceutical composition of morphine in ready-to-use injectable solution form and single dosage form of morphine for epidural or intrathecal administration
CN208838863U (zh) 一种适用于妇产科的给药器
CN107496425A (zh) 阿伐那非(Avanafil)在制备慢性阻塞性肺疾病药物中的应用及其药物组合物
JPH0214058B2 (hr)
CN102120026A (zh) 以醇作为增溶剂的21(s)阿加曲班静脉注射液
CN209270373U (zh) 一种镭射成型释药孔的缓释药载体
RU2363420C2 (ru) Способ гемосорбции у собак
CN205626700U (zh) 一种肛肠科给药器
CN215192067U (zh) 一种麻醉阻滞针
Nayak Permissive hypercapnia: Is there any upper limit?
CN203291330U (zh) 一种耳鼻喉科护理用喷药器装置
CN203447595U (zh) 吸引型可视喉头喷雾器
CN103169970A (zh) 一种治疗病毒性肺炎的药物组合物